2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014

DateTitle
19-Dec-2005Joseph L. Herring to Become Chairman of Covance Inc. Print
19-Dec-2005Covance Announces Plan to Repatriate Accumulated Foreign Earnings Under the Provisions of the American Jobs Creation Act Print
14-Dec-2005Covance Strengthens Drug Risk Minimization Services Team Leadership Print
29-Nov-2005Covance Continues Enhancement of Lablink Web Monitoring Tool for Clinical Trial Laboratory Tests Print
21-Nov-2005Covance Named Mortara Certified Partner For ECG Compliance With FDA's New Digital Standard Print
24-Oct-2005New NDLEA Testing Method Goes On-line at Covance Print
24-Oct-2005Covance Increases Stability Chamber Capacity Print
19-Oct-2005Covance Grows EPS 26%; Delivers Record Orders And Margins Print
15-Sep-2005Covance Study Highlights Continued Need For Off-Label Drug Use In Oncology Practice Print
23-Aug-2005Covance Increases Its Phase I Clinical Capacity With Acquisition Of GFI Research Center Print
20-Jul-2005Covance Reports Strong Earnings Growth Of 28% To $0.46 Per Share Print
18-Jul-2005Covance Supports Chinese Regional Laboratory In Achieving Level 1 NGSP Certification Print
07-Jul-2005Covance Laboratories Continues Expansion Of Biotechnology Services Group Print
27-Jun-2005Covance Acquires Antibodies Product Line Of Sternberger Monoclonals Print
06-Jun-2005Covance Files Lawsuit Against PETA And Its Infiltrator Print
20-Apr-2005Covance Reports EPS Growth Of 32.4% To $0.45 Print
23-Mar-2005Covance and Expression Analysis Team to Provide Genomic Microarray Testing Services for Clinical Trials Print
21-Feb-2005Covance Clinical Research Unit in Leeds Opens New GMP Pharmacy Print
26-Jan-2005Covance Grows 2004 EPS 26% To $1.52/Share Print
17-Jan-2005Covance Expands Capabilities Of Lablink Web Monitoring Tool For Clinical Trial Laboratory Tests Print